Return to Index

• Biogen Earnings, Drug Data to Lift Biotech ETFs

  April 21st by John Spence

  Biogen (NasdaqGS: BIIB) shares jumped more than 20% in premarket action Thursday after the company...

  READ MORE

• ETFs And A Global Approach Help Investors Access Biotech

  March 11th by Tom Lydon

  Investing in biotech stocks and companies is so much like gambling, the risk is sometimes not worth...

  READ MORE

• 5 Biotechnology ETFs to Play Innovation

  February 22nd by Tom Lydon

  While the broader market has picked up its pace, the biotechnology sector has not seen a similar...

  READ MORE

• ETFs Turn Sunny Side Up on M&A and Earnings

  February 16th by Tom Lydon

  Reversing a few days of weak starts, exchange traded funds (ETFs) opened higher as investors...

  READ MORE

• Sector ETFs to Play the State of the Union Address

  January 26th by Tom Lydon

  In his State of the Union address Tuesday, President Barack Obama touched upon the major problems...

  READ MORE

• Dissipate the Risk In Biotechnology With ETFs

  January 18th by Tom Lydon

  The biotechnology sector offers investors the opportunity to bet big and win big, but the potential...

  READ MORE

• Play the Booming Biotech Sector With ETFs

  December 21st by Tom Lydon

  Economic downturn? What economic downturn? Despite lackluster economic growth, biotechnology...

  READ MORE

• « Older Entries
• Newer Entries »